Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Testing revenue326.54M90.44%
Biopharmaceutical and other revenue18.92M5.24%
Product revenue15.59M4.32%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States334.53M92.65%
International26.53M7.35%
